These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22118169)

  • 21. [Comparison of conventional tuberculin skin test and QFT-2G, a new method for diagnosis of tuberculosis infection, with the use of the contact score].
    Fujiyama R; Higuchi J; Shirai C; Kawakami Y; Iwamoto T; Suzuki K; Okada Z; Sakatani M; Mori T; Wakabayashi I
    Kekkaku; 2011 Nov; 86(11):869-77. PubMed ID: 22250466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors That Contribute to Indeterminate Results From the QuantiFERON-TB Gold In-Tube Test in Patients With Inflammatory Bowel Disease.
    Kaur M; Singapura P; Kalakota N; Cruz G; Shukla R; Ahsan S; Tansel A; Thrift AP; El-Serag HB
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1616-1621.e1. PubMed ID: 29175527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals.
    Jones S; de Gijsel D; Wallach FR; Gurtman AC; Shi Q; Sacks H
    Int J Tuberc Lung Dis; 2007 Nov; 11(11):1190-5. PubMed ID: 17958980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of the QuantiFERON-TB Gold test for screening tuberculosis contacts and predicting active disease.
    Yoshiyama T; Harada N; Higuchi K; Sekiya Y; Uchimura K
    Int J Tuberc Lung Dis; 2010 Jul; 14(7):819-27. PubMed ID: 20550763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment.
    Sauzullo I; Mengoni F; Scrivo R; Valesini G; Potenza C; Skroza N; Marocco R; Lichtner M; Vullo V; Mastroianni CM
    Int J Tuberc Lung Dis; 2010 Jul; 14(7):834-40. PubMed ID: 20550765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-gamma release assay for diagnosing Mycobacterium tuberculosis infections in patients with systemic lupus erythematosus.
    Takeda N; Nojima T; Terao C; Yukawa N; Kawabata D; Ohmura K; Usui T; Fujii T; Ito Y; Iinuma Y; Mimori T
    Lupus; 2011 Jul; 20(8):792-800. PubMed ID: 21562022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adapted T cell interferon-gamma release assay for the diagnosis of pleural tuberculosis.
    Ates G; Yildiz T; Ortakoylu MG; Ozekinci T; Erturk B; Akyildiz L; Caglar E
    Respiration; 2011; 82(4):351-7. PubMed ID: 21293103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High rate of indeterminate results of the QuantiFERON-TB Gold in-tube test, third generation, in patients with systemic vasculitis.
    Rousset S; Treiner E; Moulis G; Pugnet G; Astudillo L; Paricaud K; Puissant-Lubrano B; Arlet P; Blancher A; Sailler L
    Rheumatology (Oxford); 2020 May; 59(5):1006-1010. PubMed ID: 31518431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
    Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
    J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic performance of whole-blood interferon-γ assay and enzyme-linked immunospot assay for active tuberculosis'.
    Lai CC; Tan CK; Lin SH; Liao CH; Huang YT; Hsueh PR
    Diagn Microbiol Infect Dis; 2011 Oct; 71(2):139-43. PubMed ID: 21840675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute effect of low-flux hemodialysis process on the results of the interferon-gamma-based QuantiFERON-TB Gold In-Tube test in end-stage renal disease patients.
    Hursitoglu M; Cikrikcioglu MA; Tukek T; Beycan I; Ahmedova N; Karacuha S; Sansal M; Ozkan O; Celik V
    Transpl Infect Dis; 2009 Feb; 11(1):28-32. PubMed ID: 18803615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuberculosis infection in drug users: interferon-gamma release assay performance.
    Grimes CZ; Hwang LY; Williams ML; Austin CM; Graviss EA
    Int J Tuberc Lung Dis; 2007 Nov; 11(11):1183-9. PubMed ID: 17958979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive values of QuantiFERON-TB Gold testing in screening for tuberculosis disease in asylum seekers.
    Harstad I; Winje BA; Heldal E; Oftung F; Jacobsen GW
    Int J Tuberc Lung Dis; 2010 Sep; 14(9):1209-11. PubMed ID: 20819271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals.
    Aichelburg MC; Rieger A; Breitenecker F; Pfistershammer K; Tittes J; Eltz S; Aichelburg AC; Stingl G; Makristathis A; Kohrgruber N
    Clin Infect Dis; 2009 Apr; 48(7):954-62. PubMed ID: 19245343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Latent Tuberculosis screening using interferon-gamma release assays in an Australian HIV-infected cohort: is routine testing worthwhile?
    Doyle JS; Bissessor M; Denholm JT; Ryan N; Fairley CK; Leslie DE
    J Acquir Immune Defic Syndr; 2014 May; 66(1):48-54. PubMed ID: 24457631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of the QuantiFERON-TB Gold test to confirm latent tuberculosis infection in a Canadian tuberculosis clinic.
    Kunimoto D; Der E; Beckon A; Thomas L; Egedahl M; Beatch A; Williams G; Tyrrell G; Ahmed R; Brown N; Long R
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):726-30. PubMed ID: 19460248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective large-scale study of methods for the detection of latent Mycobacterium tuberculosis infection in refugee children.
    Lucas M; Nicol P; McKinnon E; Whidborne R; Lucas A; Thambiran A; Burgner D; Waring J; French M
    Thorax; 2010 May; 65(5):442-8. PubMed ID: 20435869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases.
    Soborg B; Ruhwald M; Hetland ML; Jacobsen S; Andersen AB; Milman N; Thomsen VO; Jensen DV; Koch A; Wohlfahrt J; Ravn P
    J Rheumatol; 2009 Sep; 36(9):1876-84. PubMed ID: 19648300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validity of interferon-γ-release assays for the diagnosis of latent tuberculosis in haemodialysis patients.
    Chung WK; Zheng ZL; Sung JY; Kim S; Lee HH; Choi SJ; Yang J
    Clin Microbiol Infect; 2010 Jul; 16(7):960-5. PubMed ID: 19906274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinguishing tuberculosis from Mycobacterium avium complex disease using an interferon-gamma release assay.
    Ra SW; Lyu J; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
    Int J Tuberc Lung Dis; 2011 May; 15(5):635-40. PubMed ID: 21756514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.